Oxford Cannabinoid Technologies, which counts tobacco giant Imperial Brands Plc and rapper Snoop Dogg among its investors, swung between big gains and losses as it debuted on the London Stock Exchange.
Oxford Cannabinoid Technologies, the U.K. prescription drug company that counts rapper Snoop Dogg among its investors, swung wildly between gains and losses on its London stock-market debut, capping a volatile week for investors.
Oxford Cannabinoid Technologies, which counts tobacco giant Imperial Brands Plc and rapper Snoop Dogg among its investors, is set to start trading Friday on the London Stock Exchange.
Jazz Pharmaceuticals and Horizon Therapeutics are among a cadre of accelerating medical stocks, while big names like Iqvia Holdings are hitting the brakes.
Late Tuesday, Jazz Pharma reported adjusted earnings of $3.92 per share on $607.58 million in sales for its first quarter. Jazz stock was unmoved.
GW’s ground-breaking medicines development programme recognised for outstanding achievement in innovation with UK’s highest official award for British business
Are Medical Marijuana Stock Going To Make Investors Rich In The Future?
Jazz is about to get the top cannabis-derived drug on the market, in addition to a robust pipeline.
Are These Top Cannabis Stocks To Invest In Right Now?
The Techncial Trigger Driven Stock Trade in GW Pharmaceuticals PLC (NASDAQ:GWPH) .